Aginko Research

Executive Summary

Aginko Research, headquartered in Lausanne, Switzerland, is a premier provider of comprehensive pre-clinical laboratory services and clinical trial management solutions for the pharmaceutical, biotechnology, and medical device industries. Founded in 2016, the company specializes in accelerating the development of innovative treatments through a full range of in vivo and in vitro testing, biomarker discovery, and regulatory pathway support. By ensuring precision and expertise at every stage, Aginko enables clients to streamline their pre-clinical and clinical processes, reducing time-to-market for new therapies. As a private entity with a pre-clinical stage focus, the company serves as a critical partner in the drug development ecosystem, particularly for emerging biotech firms lacking internal capabilities. Despite limited public information, Aginko's established presence in the diagnostics and service sector positions it well within the growing outsourced research market, which is driven by increasing R&D costs and the need for specialized expertise.

Upcoming Catalysts (preview)

• Q2 2026Expansion of laboratory facilities or service offerings70% success
• Q3 2026Strategic partnership with a major pharmaceutical or biotech company60% success
• Q4 2026Achievement of regulatory certification (e.g., GLP or ISO accreditation)80% success